Foslevodopa/Foscarbidopa Is Well Tolerated and Maintains Stable Levodopa and Carbidopa Exposure Following Subcutaneous Infusion

BACKGROUND: Foslevodopa/foscarbidopa, formerly known as ABBV-951, is a formulation of levodopa/carbidopa prodrugs with solubility that allows for subcutaneous (SC) infusion and is in development for the treatment of motor complications for patients with advanced Parkinson’s disease (aPD). OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosebraugh, Matthew, Liu, Wei, Neenan, Melina, Facheris, Maurizio F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609688/
https://www.ncbi.nlm.nih.gov/pubmed/34366380
http://dx.doi.org/10.3233/JPD-212813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609688/
https://www.ncbi.nlm.nih.gov/pubmed/34366380
http://dx.doi.org/10.3233/JPD-212813

Ejemplares similares